LU85269A1 - Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux - Google Patents

Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux Download PDF

Info

Publication number
LU85269A1
LU85269A1 LU85269A LU85269A LU85269A1 LU 85269 A1 LU85269 A1 LU 85269A1 LU 85269 A LU85269 A LU 85269A LU 85269 A LU85269 A LU 85269A LU 85269 A1 LU85269 A1 LU 85269A1
Authority
LU
Luxembourg
Prior art keywords
somatostatin
compounds
preparation
treatment
animals
Prior art date
Application number
LU85269A
Other languages
English (en)
French (fr)
Inventor
Professeur G Hennen
M J Closset
M Minh Dit Sato
Original Assignee
Techland S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU85269(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Techland S A filed Critical Techland S A
Priority to LU85269A priority Critical patent/LU85269A1/fr
Priority to NO851084A priority patent/NO851084L/no
Priority to DE8585870041T priority patent/DE3560949D1/de
Priority to AT85870041T priority patent/ATE30729T1/de
Priority to EP85870041A priority patent/EP0157753B1/de
Priority to JP60060517A priority patent/JPS60222499A/ja
Priority to IL74701A priority patent/IL74701A0/xx
Priority to DK133085A priority patent/DK133085A/da
Priority to ES541532A priority patent/ES8605147A1/es
Priority to ZA852224A priority patent/ZA852224B/xx
Priority to PT80159A priority patent/PT80159B/pt
Priority to AU40374/85A priority patent/AU4037485A/en
Priority to GR850746A priority patent/GR850746B/el
Priority to KR1019850001984A priority patent/KR850006942A/ko
Publication of LU85269A1 publication Critical patent/LU85269A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
LU85269A 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux LU85269A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
LU85269A LU85269A1 (fr) 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
NO851084A NO851084L (no) 1984-03-26 1985-03-19 Fremgangsmaate til fremstilling av somatostatinforbindeler
DE8585870041T DE3560949D1 (en) 1984-03-26 1985-03-20 New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals
AT85870041T ATE30729T1 (de) 1984-03-26 1985-03-20 Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.
EP85870041A EP0157753B1 (de) 1984-03-26 1985-03-20 Somatostatin-Derivate, Verfahren zu ihrer Herstellung, die sie enthaltenden veterinären Zusammensetzungen und Verfahren zur Behandlung von Tieren
PT80159A PT80159B (en) 1984-03-26 1985-03-25 New somatostatin compounds process for their synthesis preparation for veterinary use containing said compounds and process for the treatment of animals
IL74701A IL74701A0 (en) 1984-03-26 1985-03-25 New somatostatin compounds,process for their synthesis,preparation for veterinary use containing said compounds and process for the treatment of animals
JP60060517A JPS60222499A (ja) 1984-03-26 1985-03-25 新規ソマトスタチン、その製造法、上記化合物を含有する獣医使用のための製剤、および動物処置法
DK133085A DK133085A (da) 1984-03-26 1985-03-25 Somatostatinderivater, fremgangsmaade til fremstilling deraf, veterinaert praeparat indeholdende saadanne forbindelser og fremgangsmaade til behandling af dyr
ES541532A ES8605147A1 (es) 1984-03-26 1985-03-25 Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos
ZA852224A ZA852224B (en) 1984-03-26 1985-03-25 New somatostatin compounds,process for their synthesis,preparation for veterinary use containing said compounds and process for the treatment of animals
AU40374/85A AU4037485A (en) 1984-03-26 1985-03-26 Muramyl peptide-somatostatin peptides
GR850746A GR850746B (de) 1984-03-26 1985-03-26
KR1019850001984A KR850006942A (ko) 1984-03-26 1985-03-26 소마토스태틴 화합물의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU85269 1984-03-26
LU85269A LU85269A1 (fr) 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux

Publications (1)

Publication Number Publication Date
LU85269A1 true LU85269A1 (fr) 1985-10-14

Family

ID=19730232

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85269A LU85269A1 (fr) 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux

Country Status (14)

Country Link
EP (1) EP0157753B1 (de)
JP (1) JPS60222499A (de)
KR (1) KR850006942A (de)
AT (1) ATE30729T1 (de)
AU (1) AU4037485A (de)
DE (1) DE3560949D1 (de)
DK (1) DK133085A (de)
ES (1) ES8605147A1 (de)
GR (1) GR850746B (de)
IL (1) IL74701A0 (de)
LU (1) LU85269A1 (de)
NO (1) NO851084L (de)
PT (1) PT80159B (de)
ZA (1) ZA852224B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599229A (en) * 1985-09-09 1986-07-08 International Minerals & Chemical Corp. Method of promoting animal growth using antibodies against somatostatin
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5552534A (en) * 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
WO1993013791A1 (en) * 1992-01-20 1993-07-22 Peptech (Uk) Limited Use of muramyl peptides for enhancing animal production
IT1283134B1 (it) * 1996-07-08 1998-04-07 Dox Al Italia Spa Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in
WO2001036643A1 (en) 1999-11-19 2001-05-25 Transkaryotic Therapies, Inc. Nucleic acid construct for optimized production of products
FR2852247A1 (fr) * 2003-03-11 2004-09-17 Centre Nat Rech Scient Utilisation de ligands peptidiques de recepteurs de la membrane plasmique et de leurs analogues pour moduler l'activite des mitochondries
CA2847336C (en) 2011-09-04 2021-09-07 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide
CA2847334C (en) 2011-09-04 2020-09-01 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Also Published As

Publication number Publication date
KR850006942A (ko) 1985-10-25
DK133085D0 (da) 1985-03-25
ES541532A0 (es) 1986-04-01
PT80159B (en) 1986-11-10
ES8605147A1 (es) 1986-04-01
DK133085A (da) 1985-09-27
JPS60222499A (ja) 1985-11-07
EP0157753A1 (de) 1985-10-09
ATE30729T1 (de) 1987-11-15
NO851084L (no) 1985-09-27
AU4037485A (en) 1985-10-03
EP0157753B1 (de) 1987-11-11
IL74701A0 (en) 1985-06-30
PT80159A (en) 1985-04-01
ZA852224B (en) 1985-11-27
GR850746B (de) 1986-05-13
DE3560949D1 (en) 1987-12-17

Similar Documents

Publication Publication Date Title
EP0517589B1 (de) Tachykininderivate, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69125537T2 (de) Alpha-keto-amidderivate mit Protease inhibierender Aktivität
EP0190058A1 (de) Peptidderivate mit polyzyklischer Stickstoffstruktur, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
FR2621317A1 (fr) Tripeptides doues de proprietes immunostimulantes et antimetastasiques et procede pour leur preparation
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
LU85269A1 (fr) Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
EP0401109A1 (de) Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel
FUJINO et al. A new procedure for the pentachlorophenylation of N-protected amino acids
JPS6317839B2 (de)
EP0171315B1 (de) Verfahren zur Herstellung von hGRF (Somatocrinin) in flüssiger Phase und Peptidezwischenverbindungen
EP0292729A2 (de) Neue Festphasen-Peptidsynthesemethoden
US5138061A (en) Thioacylating reagents
US4748154A (en) Peptide derivatives, their production and use
FR2522655A1 (fr) Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
FR2535715A1 (fr) Peptides biologiquement actifs, procede pour leur preparation et leur emploi comme medicaments
FR2595705A1 (fr) Derives de gonadoliberine contenant un acide aminocarboxylique aromatique en position 6, compositions pharmaceutiques et veterinaires les contenant et procede pour les preparer
EP0331073B1 (de) Benzhydrylamin-Derivate
FR2513994A1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
EP0295540B1 (de) Allylische Seitenketten enthaltendes Festphasensystem, Verfahren zu seiner Herstellung und seine Verwendung in Festphasenreaktionen
CA1273750A (fr) Analogues de composes polypeptidiques hypocalcemiants epargnant le calcium de l'organisme, leur preparation, leur application a titre de medicaments et les compositions les renfermant
FR2543546A1 (fr) Derives de gonadoreline contenant un groupe b-aspartyle, procede pour leur preparation et preparations pharmaceutiques les contenant
EP0354108A1 (de) Aminosäuren und Peptide mit einem modifizierten Tyrosin, ihre Herstellung und ihre Verwendung als Medikamente
EP0165151A1 (de) Peptid-Derivate, Hemmungsstoffe von Renin, deren Verfahren zur Herstellung und deren therapeutische Verwendung
FR2521133A1 (fr) Nouvel heptadecapeptide a effet de liberation d'hormone de croissance et medicament le contenant
EP0565607B1 (de) Schutzgruppe, durch diese gruppe geschützte verbindung, und vorrichtung zum anbringen der schutzgruppe an die zu schützenden verbindung